Intellect Design Arena (INTELLECT) near Rs 505: Is the 16% share-price crash justified when AI revenue is growing but profits are not?
Read More Pharma Industry News BeiGene gets Brukinsa FDA approval for chronic lymphocytic leukemia BeiGene has secured the approval of the US Food and Drug Administration (FDA) for the company’s Brukinsa (zanubrutinib)… byRaghuram KadariJanuary 21, 2023